申请人:Burgdorf Lars
公开号:US20100331338A1
公开(公告)日:2010-12-30
Novel compounds of the Formula (I) in which R
1
, R
2
, R
3
, and R
4
have the meanings indicated in Claim
1,
are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Type 1 and 2, obesity, neuropathy and/or nephropathy.
公式(I)中的新化合物,其中R1、R2、R3和R4具有声明1中指示的含义,是葡萄糖激酶的活化剂,可用于预防和/或治疗1型和2型糖尿病、肥胖症、神经病和/或肾病。